Further Information:
The Health Products Regulatory Authority has been notified of a shortage of the following products:
- Caverject 20mcg Powder and Solvent for Solution for Injection – PA0822/115/003
- Metalyse 10,000 Units Powder and Solvent for Solution for Injection – EU/1/00/169/006
The following shortages have been resolved and supply has resumed to the Irish market:
- Abstral 100mcg Sublingual Tablet – PA2288/004/002
- Abstral 200mcg Sublingual Tablet – PA2288/004/003
- Abstral 400mcg Sublingual Tablet – PA2288/004/005
- Abstral 600mcg Sublingual Tablet – PA2288/004/006
- Abstral 800mcg Sublingual Tablet – PA2288/004/007
- Diltam 90mg Prolonged Release Tablet – PA0711/004/002
- Flixotide 0.5mg/2ml Nebules – PA1077/044/016
- HBVAXPRO 5mcg Suspension for Injection in Prefilled Syringe – EU/1/01/183/004
- Ibuprofen 400mg Solution for Infusion – PA0736/041/001
- Marcain Heavy Steripack 0.5% w/v Solution for Injection – PA1691/024/003
- Sodium bicarbonate 8.4% w/v Intravenous Infusion – PA0179/006/001
- Valaciclovir 500mg Film Coated Tablet – PA0749/036/001
Please see the shortages section of the HPRA website for further information.
The HPRA will be sending weekly updates concerning medicinal product shortages. However, the above webpage will be updated as new information is provided to the HPRA.